Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial. Gonzales MM, Garbarino VR, Kautz TF, Palavicini JP, et al. Nat Med 2023 Sep 7. doi: 10.1038/s41591-023-02543.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gonzales MM, Garbarino VR, Kautz TF, Palavicini JP, et al. Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial. Nat Med 2023 Sep 7. doi: 10.1038/s41591-023-02543.
PMID: 37679434